Mannkind (MNKD) Gross Margin (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 411.00 |
| Dec 31, 2025 | -696.00 |
| Sep 30, 2025 | 54.00 |
| Jun 30, 2025 | -121.00 |
| Mar 31, 2025 | 145.00 |
| Dec 31, 2024 | -170.00 |
| Sep 30, 2024 | 318.00 |
| Jun 30, 2024 | -198.00 |
| Mar 31, 2024 | -3,978.00 |
| Dec 31, 2023 | 6,024.00 |
| Sep 30, 2023 | 258.00 |
| Jun 30, 2023 | 396.00 |
| Mar 31, 2023 | -10,524.00 |
| Dec 31, 2022 | 11,373.00 |
| Sep 30, 2022 | 149,775.00 |
| Jun 30, 2022 | -143,286.00 |
| Mar 31, 2022 | 15,747.00 |
| Dec 31, 2021 | -24,644.00 |
| Sep 30, 2021 | 178.00 |
| Jun 30, 2021 | 580.00 |
| Mar 31, 2021 | -495.00 |
| Dec 31, 2020 | 359.00 |
| Sep 30, 2020 | 181,511.00 |
| Jun 30, 2020 | -181,285.00 |
| Mar 31, 2020 | 331.00 |
| Dec 31, 2019 | 98,518.00 |
| Sep 30, 2019 | 114,936.00 |
| Jun 30, 2019 | -214,046.00 |
| Mar 31, 2019 | 806.00 |
| Dec 31, 2018 | 8,756.00 |
| Sep 30, 2018 | 1,221.00 |
| Jun 30, 2018 | -1,520.00 |
| Mar 31, 2018 | -490.00 |
| Dec 31, 2017 | 11,316.00 |
| Sep 30, 2017 | 1,120.00 |
| Jun 30, 2017 | -15,046.00 |
| Mar 31, 2017 | -5,075.00 |
| Dec 31, 2016 | -3,123.00 |